Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer’s disease

While axonopathy is a prominent feature in a variety of neurodegenerative diseases, it has been largely neglected in Alzheimer’s disease (AD), despite the observation of frequent motoric deficits in AD patients. In the present report we used transgenic mice overexpressing human mutant β-amyoid precursor protein (APP751SL) and presenilin-1 (PS1M146L) that exhibit elevated intraneuronal Aβ42 levels. We observed abundant age-dependent axonopathy in the spinal cord: axons immunopositive for ubiquitin in the dorsal column; axonal swellings (spheroids) which accumulated APP, neurofilament, and ubiquitin; as well as myelin ovoid structures, which serve as markers for nerve fiber degeneration in both white and gray matter. Both descending and ascending axonal tracts in white matter were affected. Neuritic plaques also developed in an age-dependent manner starting in the cervical region. Furthermore, early intraneuronal Aβ was detected in some but not all motor neurons before plaque formation. In the present APP/PS1 transgenic mouse model we could show for the first time that elevated intracellular Aβ levels lead to an axonopathy characterized by the formation of axonal spheroids and myelin ovoids. The same pathological alterations are known from AD patients or transgenic models overexpressing Tau or ApoE, however, these disturbances in axonal transport occur in the absence of any signs of concomitant Tau pathology. This strengthens the prevailing amyloid hypothesis as a primary trigger of AD-typical pathological alterations.

[1]  S. O’Keeffe,et al.  Gait disturbance in Alzheimer's disease: a clinical study. , 1996, Age and ageing.

[2]  H. Steinbusch,et al.  Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. , 2004, The American journal of pathology.

[3]  T. Bayer,et al.  Intraneuronal APP/A beta trafficking and plaque formation in beta-amyloid precursor protein and presenilin-1 transgenic mice. , 2002, Brain pathology.

[4]  P. Greengard,et al.  Intraneuronal Abeta42 accumulation in human brain. , 2000, The American journal of pathology.

[5]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[6]  D. Price,et al.  Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[7]  T. Bayer,et al.  Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. , 2004, The American journal of pathology.

[8]  P. Greengard,et al.  Intraneuronal Aβ42 Accumulation in Human Brain , 2000 .

[9]  C. Masters,et al.  Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion. , 1999, The Biochemical journal.

[10]  S. Murayama,et al.  Expression of tau immunoreactivity in the spinal motor neurons of Alzheimer's disease , 2000, Neurology.

[11]  Kazuko Hasegawa,et al.  Kinesin and cytoplasmic dynein in spinal spheroids with motor neuron disease , 1998, Journal of the Neurological Sciences.

[12]  M. Beal,et al.  Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients. , 2005, Neurobiology of disease.

[13]  Oliver Wirths,et al.  Intraneuronal Aβ accumulation precedes plaque formation in β-amyloid precursor protein and presenilin-1 double-transgenic mice , 2001, Neuroscience Letters.

[14]  L. Goldstein,et al.  Kinesin-mediated axonal transport of a membrane compartment containing β-secretase and presenilin-1 requires APP , 2001, Nature.

[15]  J. Brandt,et al.  Motor signs during the course of Alzheimer disease , 2004, Neurology.

[16]  M. Beal,et al.  β-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients , 2005, Neurobiology of Disease.

[17]  Mark P Mattson,et al.  Alzheimer's Presenilin 1 Mutations Impair Kinesin-Based Axonal Transport , 2003, The Journal of Neuroscience.

[18]  L. Cork,et al.  Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease , 1993, Cell.

[19]  J. Trojanowski,et al.  Spinal Cord Neurofibrillary Pathology in Alzheimer Disease and Guam Parkinsonism‐Dementia Complex , 2001, Journal of neuropathology and experimental neurology.

[20]  D. Price,et al.  Axonal Transport, Amyloid Precursor Protein, Kinesin-1, and the Processing Apparatus: Revisited , 2005, The Journal of Neuroscience.

[21]  T. Bayer,et al.  Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. , 2001, Neuroscience letters.

[22]  T. Bayer,et al.  A modified β‐amyloid hypothesis: intraneuronal accumulation of the β‐amyloid peptide – the first step of a fatal cascade , 2004, Journal of neurochemistry.

[23]  T. Bayer,et al.  Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice , 2003, Experimental Neurology.

[24]  L. Goldstein,et al.  Axonal Transport of Amyloid Precursor Protein Is Mediated by Direct Binding to the Kinesin Light Chain Subunit of Kinesin-I , 2000, Neuron.

[25]  J. Hanover,et al.  Cessation of rapid late endosomal tubulovesicular trafficking in Niemann–Pick type C1 disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  B. Crain,et al.  Autosomal dominant juvenile amyotrophic lateral sclerosis. , 1999, Brain : a journal of neurology.

[27]  R. A. Crowther,et al.  Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein , 2000, Acta Neuropathologica.

[28]  S. Ohara,et al.  Axonal dystrophy of dorsal root ganglion sensory neurons in a mouse model of Niemann–Pick disease type C , 2004, Experimental Neurology.

[29]  T. Bayer,et al.  Key Factors in Alzheimer's Disease: β‐amyloid Precursor Protein Processing, Metabolism and Intraneuronal Transport , 2001, Brain pathology.

[30]  Bin Zhang,et al.  Axonal transport defects: a common theme in neurodegenerative diseases , 2005, Acta Neuropathologica.

[31]  K. Ogomori,et al.  Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease. , 1989, The American journal of pathology.

[32]  H. Geerts,et al.  Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. , 1999, The American journal of pathology.

[33]  J. Julien,et al.  Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis , 1993, Cell.

[34]  S. Saxena,et al.  Trophic Factors in Neurodegenerative Disorders , 2003, IUBMB life.

[35]  M. Szyf,et al.  Rat transgenic models with a phenotype of intracellular Abeta accumulation in hippocampus and cortex. , 2004, Journal of Alzheimer's disease : JAD.

[36]  I. Tesseur,et al.  Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord. , 2000, The American journal of pathology.

[37]  M. Gurney,et al.  Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[38]  J. Julien,et al.  A neurotoxic peripherin splice variant in a mouse model of ALS , 2003, The Journal of cell biology.

[39]  Oliver Wirths,et al.  Intraneuronal APP/Aβ Trafficking and Plaque Formation in β‐Amyloid Precursor Protein and Presenilin‐1 Transgenic Mice , 2002 .

[40]  E. Masliah,et al.  Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease , 2005, Science.

[41]  S. Yagishita.  Morphological investigations on axonal swellings and spheroids in various human diseases , 1978, Virchows Archiv A.